Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies
- 9 June 2006
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 33 (10), 1196-1205
- https://doi.org/10.1007/s00259-006-0139-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibodyJournal of Controlled Release, 2004
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002
- Liposomal cancer chemotherapy: current clinical applications and future prospectsExpert Opinion on Investigational Drugs, 2001
- High Intratumoral Accumulation of Stealth Liposomal Doxorubicin in Sarcomas: Rationale for Combination with RadiotherapyActa Oncologica, 2000
- Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cellsImmunology Letters, 1995
- Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: Targeted MRI contrast enhancement agents for the liverMagnetic Resonance in Medicine, 1991
- A Pharmacokinetic and MRI Study of Unilamellar Gadolinium-, Manganese-, and Iron-DTPA-Stearate Liposomes as Organ-Specific Contrast AgentsInvestigative Radiology, 1990
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990